nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—PTGS2—Risedronate—osteoporosis	0.198	0.221	CbGbCtD
Phenylbutazone—SLC22A11—Conjugated Estrogens—osteoporosis	0.129	0.145	CbGbCtD
Phenylbutazone—SLC22A11—Estradiol—osteoporosis	0.114	0.127	CbGbCtD
Phenylbutazone—SLC22A8—Conjugated Estrogens—osteoporosis	0.0753	0.084	CbGbCtD
Phenylbutazone—SLC22A8—Estradiol—osteoporosis	0.0661	0.0738	CbGbCtD
Phenylbutazone—SLC22A6—Conjugated Estrogens—osteoporosis	0.0524	0.0585	CbGbCtD
Phenylbutazone—CYP2C9—Estropipate—osteoporosis	0.0509	0.0568	CbGbCtD
Phenylbutazone—CYP3A4—Estropipate—osteoporosis	0.0296	0.033	CbGbCtD
Phenylbutazone—CYP3A4—Calcitriol—osteoporosis	0.0296	0.033	CbGbCtD
Phenylbutazone—CYP2C9—Cholecalciferol—osteoporosis	0.0262	0.0293	CbGbCtD
Phenylbutazone—CYP3A4—Ergocalciferol—osteoporosis	0.0237	0.0264	CbGbCtD
Phenylbutazone—CYP2C9—Estradiol—osteoporosis	0.0211	0.0236	CbGbCtD
Phenylbutazone—CYP3A4—Raloxifene—osteoporosis	0.0197	0.022	CbGbCtD
Phenylbutazone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0191	0.0213	CbGbCtD
Phenylbutazone—CYP3A4—Cholecalciferol—osteoporosis	0.0152	0.017	CbGbCtD
Phenylbutazone—CYP3A4—Conjugated Estrogens—osteoporosis	0.014	0.0156	CbGbCtD
Phenylbutazone—CYP3A4—Estradiol—osteoporosis	0.0123	0.0137	CbGbCtD
Phenylbutazone—PTGIS—Disease—ACP5—osteoporosis	0.000205	0.00196	CbGpPWpGaD
Phenylbutazone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000203	0.00195	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—IL6—osteoporosis	0.000201	0.00193	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000201	0.00192	CbGpPWpGaD
Phenylbutazone—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000201	0.00192	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000196	0.00188	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—SOD2—osteoporosis	0.000193	0.00185	CbGpPWpGaD
Phenylbutazone—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	0.000191	0.00183	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—TPI1—osteoporosis	0.00019	0.00182	CbGpPWpGaD
Phenylbutazone—PTGS1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000188	0.0018	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000188	0.0018	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—IDH2—osteoporosis	0.000187	0.0018	CbGpPWpGaD
Phenylbutazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000184	0.00177	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—GPX1—osteoporosis	0.000184	0.00176	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—P4HB—osteoporosis	0.000179	0.00172	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—IL6—osteoporosis	0.000177	0.0017	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CYP27A1—osteoporosis	0.000176	0.00169	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—GAPDH—osteoporosis	0.000176	0.00168	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ACP5—osteoporosis	0.000171	0.00164	CbGpPWpGaD
Phenylbutazone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	0.000171	0.00164	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—MTHFR—osteoporosis	0.00017	0.00163	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000169	0.00162	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000168	0.00161	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—NFATC1—osteoporosis	0.000167	0.0016	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	0.000167	0.0016	CbGpPWpGaD
Phenylbutazone—PTGS1—Biological oxidations—CYP19A1—osteoporosis	0.000166	0.00159	CbGpPWpGaD
Phenylbutazone—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000166	0.00159	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—DKK1—osteoporosis	0.000166	0.00159	CbGpPWpGaD
Phenylbutazone—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000165	0.00158	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	0.000164	0.00157	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000164	0.00157	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—WNT1—osteoporosis	0.00016	0.00153	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—TPI1—osteoporosis	0.000159	0.00153	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000159	0.00153	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000156	0.0015	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—FGA—osteoporosis	0.000155	0.00149	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000152	0.00146	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—P4HB—osteoporosis	0.00015	0.00144	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—GAPDH—osteoporosis	0.000147	0.00141	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—RAP1A—osteoporosis	0.000143	0.00137	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—ENO1—osteoporosis	0.000138	0.00133	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PSMA5—osteoporosis	0.000136	0.00131	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PSMA2—osteoporosis	0.000136	0.00131	CbGpPWpGaD
Phenylbutazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000134	0.00128	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000134	0.00128	CbGpPWpGaD
Phenylbutazone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000132	0.00127	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.000132	0.00126	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CALCA—osteoporosis	0.000127	0.00122	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IL1B—osteoporosis	0.000127	0.00122	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000125	0.0012	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—LEP—osteoporosis	0.000125	0.0012	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000124	0.00119	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	0.000123	0.00118	CbGpPWpGaD
Phenylbutazone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000122	0.00117	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000122	0.00117	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000121	0.00116	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ENO1—osteoporosis	0.000116	0.00111	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—KL—osteoporosis	0.000115	0.00111	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	0.000115	0.0011	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PSMA2—osteoporosis	0.000114	0.00109	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PSMA5—osteoporosis	0.000114	0.00109	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000111	0.00107	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.00011	0.00105	CbGpPWpGaD
Phenylbutazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000109	0.00104	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000108	0.00104	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000106	0.00101	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000103	0.000991	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	0.000101	0.000965	CbGpPWpGaD
Phenylbutazone—PTGS1—Biological oxidations—POMC—osteoporosis	0.0001	0.000959	CbGpPWpGaD
Phenylbutazone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.9e-05	0.000949	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	9.66e-05	0.000926	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—ADCY5—osteoporosis	9.64e-05	0.000924	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—FDPS—osteoporosis	9.43e-05	0.000904	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PKM—osteoporosis	9.43e-05	0.000904	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CYP19A1—osteoporosis	9.26e-05	0.000887	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	9.21e-05	0.000882	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—ADCY5—osteoporosis	9.03e-05	0.000866	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GPD2—osteoporosis	8.94e-05	0.000857	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PGLS—osteoporosis	8.94e-05	0.000857	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PKM—osteoporosis	8.94e-05	0.000857	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SOST—osteoporosis	8.94e-05	0.000857	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	8.75e-05	0.000838	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	8.63e-05	0.000827	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ANTXR2—osteoporosis	8.48e-05	0.000812	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PGLS—osteoporosis	8.48e-05	0.000812	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MTHFR—osteoporosis	8.31e-05	0.000796	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	8.21e-05	0.000787	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	8.21e-05	0.000787	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ATIC—osteoporosis	8.18e-05	0.000784	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PNP—osteoporosis	8.18e-05	0.000784	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	8.14e-05	0.00078	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	8.11e-05	0.000778	CbGpPWpGaD
Phenylbutazone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	8.05e-05	0.000772	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	8e-05	0.000767	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	7.97e-05	0.000763	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IRS2—osteoporosis	7.9e-05	0.000757	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ADCY5—osteoporosis	7.57e-05	0.000725	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—GPX1—osteoporosis	7.54e-05	0.000723	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PKM—osteoporosis	7.49e-05	0.000718	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—FDPS—osteoporosis	7.49e-05	0.000718	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	7.43e-05	0.000712	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.35e-05	0.000704	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	7.31e-05	0.0007	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—GSN—osteoporosis	7.21e-05	0.000691	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PGLS—osteoporosis	7.1e-05	0.00068	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GPD2—osteoporosis	7.1e-05	0.00068	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	7.02e-05	0.000673	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—MTHFR—osteoporosis	6.96e-05	0.000667	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—OXCT1—osteoporosis	6.95e-05	0.000666	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CA2—osteoporosis	6.95e-05	0.000666	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IRS1—osteoporosis	6.9e-05	0.000661	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—MGLL—osteoporosis	6.78e-05	0.000649	CbGpPWpGaD
Phenylbutazone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.53e-05	0.000626	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PNP—osteoporosis	6.49e-05	0.000622	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ATIC—osteoporosis	6.49e-05	0.000622	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IL6R—osteoporosis	6.48e-05	0.000621	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.4e-05	0.000613	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.39e-05	0.000612	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—LRP5—osteoporosis	6.27e-05	0.000601	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—MYC—osteoporosis	6.2e-05	0.000595	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	6.19e-05	0.000593	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.13e-05	0.000588	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—LRP6—osteoporosis	6e-05	0.000575	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	5.9e-05	0.000565	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TNF—osteoporosis	5.78e-05	0.000554	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	5.77e-05	0.000553	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—IDH2—osteoporosis	5.76e-05	0.000552	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—RPL24—osteoporosis	5.76e-05	0.000552	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—LTF—osteoporosis	5.76e-05	0.000552	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	5.69e-05	0.000545	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—POMC—osteoporosis	5.56e-05	0.000533	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—OXCT1—osteoporosis	5.52e-05	0.000529	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CA2—osteoporosis	5.52e-05	0.000529	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.44e-05	0.000521	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP27A1—osteoporosis	5.42e-05	0.000519	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—MGLL—osteoporosis	5.38e-05	0.000516	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ACP5—osteoporosis	5.27e-05	0.000505	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—POMC—osteoporosis	5.26e-05	0.000504	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.2e-05	0.000499	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.07e-05	0.000486	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ACP5—osteoporosis	5e-05	0.000479	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—FDPS—osteoporosis	4.96e-05	0.000475	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PKM—osteoporosis	4.96e-05	0.000475	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—TPI1—osteoporosis	4.9e-05	0.00047	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PGLS—osteoporosis	4.7e-05	0.000451	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GPD2—osteoporosis	4.7e-05	0.000451	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL6—osteoporosis	4.66e-05	0.000447	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TPI1—osteoporosis	4.64e-05	0.000445	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—P4HB—osteoporosis	4.61e-05	0.000441	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—IDH2—osteoporosis	4.57e-05	0.000438	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GAPDH—osteoporosis	4.52e-05	0.000433	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—RAP1A—osteoporosis	4.4e-05	0.000422	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—P4HB—osteoporosis	4.37e-05	0.000418	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP27A1—osteoporosis	4.3e-05	0.000412	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PNP—osteoporosis	4.3e-05	0.000412	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ATIC—osteoporosis	4.3e-05	0.000412	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—GAPDH—osteoporosis	4.29e-05	0.000411	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	4.22e-05	0.000404	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	4.21e-05	0.000404	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ACP5—osteoporosis	4.18e-05	0.000401	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.13e-05	0.000396	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NFATC1—osteoporosis	4.07e-05	0.00039	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—DKK1—osteoporosis	4.04e-05	0.000387	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	3.93e-05	0.000377	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—WNT1—osteoporosis	3.89e-05	0.000373	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—TPI1—osteoporosis	3.89e-05	0.000373	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MYC—osteoporosis	3.84e-05	0.000368	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.84e-05	0.000368	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—TGFB1—osteoporosis	3.83e-05	0.000367	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGA—osteoporosis	3.79e-05	0.000363	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—P4HB—osteoporosis	3.66e-05	0.00035	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CA2—osteoporosis	3.66e-05	0.00035	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—OXCT1—osteoporosis	3.66e-05	0.00035	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GAPDH—osteoporosis	3.59e-05	0.000344	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—MGLL—osteoporosis	3.56e-05	0.000341	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ENO1—osteoporosis	3.56e-05	0.000341	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PSMA2—osteoporosis	3.51e-05	0.000336	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PSMA5—osteoporosis	3.51e-05	0.000336	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—RAP1A—osteoporosis	3.5e-05	0.000335	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—POMC—osteoporosis	3.47e-05	0.000332	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ENO1—osteoporosis	3.37e-05	0.000323	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.36e-05	0.000322	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PSMA5—osteoporosis	3.33e-05	0.000319	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PSMA2—osteoporosis	3.33e-05	0.000319	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PKM—osteoporosis	3.27e-05	0.000313	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—FDPS—osteoporosis	3.27e-05	0.000313	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GPD2—osteoporosis	3.1e-05	0.000297	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PGLS—osteoporosis	3.1e-05	0.000297	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CALCA—osteoporosis	3.1e-05	0.000297	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.05e-05	0.000292	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—IDH2—osteoporosis	3.03e-05	0.00029	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IL6—osteoporosis	2.89e-05	0.000277	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.85e-05	0.000273	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP19A1—osteoporosis	2.85e-05	0.000273	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ATIC—osteoporosis	2.84e-05	0.000272	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PNP—osteoporosis	2.84e-05	0.000272	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ENO1—osteoporosis	2.83e-05	0.000271	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—KL—osteoporosis	2.81e-05	0.00027	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PSMA2—osteoporosis	2.78e-05	0.000267	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PSMA5—osteoporosis	2.78e-05	0.000267	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ACP5—osteoporosis	2.77e-05	0.000266	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.74e-05	0.000262	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—TPI1—osteoporosis	2.58e-05	0.000247	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—P4HB—osteoporosis	2.42e-05	0.000232	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CA2—osteoporosis	2.41e-05	0.000231	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—OXCT1—osteoporosis	2.41e-05	0.000231	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GAPDH—osteoporosis	2.38e-05	0.000228	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MGLL—osteoporosis	2.35e-05	0.000225	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ADCY5—osteoporosis	2.33e-05	0.000223	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GPX1—osteoporosis	2.32e-05	0.000222	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—RAP1A—osteoporosis	2.32e-05	0.000222	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP19A1—osteoporosis	2.26e-05	0.000217	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ADCY5—osteoporosis	2.2e-05	0.000211	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—MTHFR—osteoporosis	2.14e-05	0.000205	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MTHFR—osteoporosis	2.03e-05	0.000194	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.02e-05	0.000193	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—IDH2—osteoporosis	2e-05	0.000191	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IRS2—osteoporosis	1.93e-05	0.000185	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.88e-05	0.00018	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ENO1—osteoporosis	1.87e-05	0.000179	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ADCY5—osteoporosis	1.85e-05	0.000177	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PSMA2—osteoporosis	1.84e-05	0.000177	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PSMA5—osteoporosis	1.84e-05	0.000177	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GPX1—osteoporosis	1.84e-05	0.000176	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ACP5—osteoporosis	1.83e-05	0.000175	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—POMC—osteoporosis	1.71e-05	0.000164	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—TPI1—osteoporosis	1.7e-05	0.000163	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—MTHFR—osteoporosis	1.7e-05	0.000163	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IRS1—osteoporosis	1.68e-05	0.000161	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—P4HB—osteoporosis	1.6e-05	0.000153	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6R—osteoporosis	1.58e-05	0.000152	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GAPDH—osteoporosis	1.57e-05	0.00015	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—RAP1A—osteoporosis	1.53e-05	0.000146	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.5e-05	0.000143	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—POMC—osteoporosis	1.36e-05	0.00013	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ENO1—osteoporosis	1.23e-05	0.000118	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ADCY5—osteoporosis	1.22e-05	0.000117	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GPX1—osteoporosis	1.22e-05	0.000117	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PSMA2—osteoporosis	1.22e-05	0.000117	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PSMA5—osteoporosis	1.22e-05	0.000117	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—MTHFR—osteoporosis	1.12e-05	0.000108	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP19A1—osteoporosis	9.87e-06	9.46e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MYC—osteoporosis	9.37e-06	8.98e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TGFB1—osteoporosis	9.35e-06	8.96e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—POMC—osteoporosis	8.99e-06	8.62e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ADCY5—osteoporosis	8.06e-06	7.73e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GPX1—osteoporosis	8.04e-06	7.7e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MTHFR—osteoporosis	7.42e-06	7.11e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6—osteoporosis	7.05e-06	6.75e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—POMC—osteoporosis	5.93e-06	5.68e-05	CbGpPWpGaD
